Analysts Are Bullish on Top Healthcare Stocks: Caribou Biosciences (CRBU), Oncology Institute (TOI)
TipRanks (Mon, 9-Mar 7:30 AM ET)
TipRanks (Sat, 7-Mar 8:45 AM ET)
Drug Pricing Reforms Threaten Caribou Biosciences’ Future Margins and Market Access
TipRanks (Sat, 7-Mar 1:00 AM ET)
Leerink Partners Remains a Buy on Caribou Biosciences (CRBU)
TipRanks (Fri, 6-Mar 9:45 AM ET)
TipRanks (Fri, 6-Mar 6:40 AM ET)
Clear Street Sticks to Their Buy Rating for Caribou Biosciences (CRBU)
TipRanks (Thu, 5-Mar 5:35 PM ET)
Caribou Bioscience GAAP EPS of -$0.28 beats by $0.04, revenue of $3.94M beats by $1.98M
Seeking Alpha News (Thu, 5-Mar 4:37 PM ET)
Globe Newswire (Thu, 5-Mar 4:05 PM ET)
Caribou Biosciences to Participate in Upcoming Investor Conferences
Globe Newswire (Thu, 12-Feb 4:05 PM ET)
Globe Newswire (Wed, 4-Feb 8:00 AM ET)
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
Caribou Biosciences trades on the NASDAQ stock market under the symbol CRBU.
As of March 9, 2026, CRBU stock price climbed to $1.97 with 1,591,442 million shares trading.
CRBU has a beta of 2.22, meaning it tends to be more sensitive to market movements. CRBU has a correlation of 0.22 to the broad based SPY ETF.
CRBU has a market cap of $184.13 million. This is considered a Micro Cap stock.
Last quarter Caribou Biosciences reported $4 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.04.
In the last 3 years, CRBU traded as high as $8.59 and as low as $.66.
The top ETF exchange traded funds that CRBU belongs to (by Net Assets): VTI, VXF, IBB, SCHA, NXTE.
CRBU has outperformed the market in the last year with a price return of +69.8% while the SPY ETF gained +19.7%. CRBU has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +3.7% and +9.4%, respectively, while the SPY returned -0.8% and -1.6%, respectively.
CRBU support price is $1.70 and resistance is $1.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRBU shares will trade within this expected range on the day.
